Michael R. Mcdonnell

Michael R. Mcdonnell

Independent DirectoratBiogen· In proxies 2021–2025

Pay in FY2024-5% from the year before · Biogen stock -40.9% the same year

Michael R. Mcdonnell was paid $6.8M in FY2024 (Dec), down 5%. Biogen stock fell 40.9% that year.

Pay$100 in the stock at the end of FY20 → $62
Pay is from the Summary Compensation Table of each Biogen proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Baxter InternationalPublic company · 1 yr
    • Independent Director2025 – Present · 1 yrNo stock prices for these years
  2. Merit Medical SystemsPublic company · 1 yr
    • Independent Director2025 – Present · 1 yrNo stock prices for these years
  3. BiogenPublic company · 5 yr
    • Executive Vice President, Chief Financial Officer2021 – Present · 5 yrStock in role -2%
  4. Merit Medical Systems, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Baxter InternationalDirector · -1 yr on the boardIndependentAudit—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?